Relationship between reactive nitrogen intermediates and total immunoglobulin E, soluble CD21 and soluble CD23: Comparison between cerebral malaria and nonsevere malaria

Parasite Immunology

Volumn 24, Issue 8, 2002, Pages 395-399

  Nacher, Mathieu ^a,b   Singhasivanon, Pratap ^b   Kaewkungwal, Jaranit ^b   Silachamroon, Udomsak ^b   Treeprasertsuk, Sombat ^b   Tosukhowong, Thanawat ^b   Vannaphan, Suparp ^b   Looareesuwan, Sornchai ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Cerebral malaria; Epstein Barr virus; IgE; Nitric oxide; Soluble CD21; Soluble CD23

Indexed keywords

CD23 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN E; REACTIVE NITROGEN SPECIES;

ADULT; ANTIGEN DETECTION; ARTICLE; BRAIN MALARIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; HUMAN; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MULTIPLE REGRESSION; MULTIVARIATE ANALYSIS; OPTICAL DENSITY; PRIORITY JOURNAL; SOLUBILITY;

ANIMALS; CASE-CONTROL STUDIES; HUMANS; IMMUNOGLOBULIN E; LOGISTIC MODELS; MALARIA; MALARIA, CEREBRAL; MULTIVARIATE ANALYSIS; ODDS RATIO; PLASMODIUM FALCIPARUM; REACTIVE NITROGEN SPECIES; RECEPTORS, COMPLEMENT 3D; RECEPTORS, IGE; SOLUBILITY;

HUMAN HERPESVIRUS 4; PROTOZOA;

EID: 0036428773     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.2002.00481.x     Document Type: Article

References (18)

1. WHO. Severe falciparum malaria. Trans Royal Soc Trop Med Hygiene 2000; 94: 1-90.
2. Plebanski M, Hill AV. The immunology of malaria infection. Curr Opin Immunol 2000; 12: 437-441.
3. Al Yaman FM, Mokela D, Genton B, Rockett KA, Alpers MP, Clark IA. Association between serum levels of reactive nitrogen intermediates and coma in children with cerebral malaria in Papua New Guinea. Trans Royal Soc Trop Med Hygiene 1996; 90: 270-273.
4. Maneerat Y, Viriyavejakul P, Punpoowong B et al. Inducible nitric oxide synthase expression is increased in the brain in fatal cerebral malaria. Histopathology 2000; 37: 269-277.
5. Anstey NM, Weinberg JB, Hassanali MY et al. Nitric oxide in Tanzanian children with malaria: Inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med 1996; 184: 557-567.
6. Perlmann P, Perlmann H, Flyg BW et al. Immunoglobulin E, a pathogenic factor in Plasmodium falciparum malaria. Infect Immun 1997; 65: 116-121.
7. Maeno Y, Steketee RW, Nagatake T et al. Immunoglobulin complex deposits in Plasmodium falciparum-infected placentas from Malawi and Papua New Guinea. Am J Trop Med Hygiene 1993; 49: 574-580.
8. Nacher M, Gay F, Singhasivanon P et al. Ascaris lumbricoides infection is associated with protection from cerebral malaria. Parasite Immunol 2000; 22: 107-113.
9. Dugas B, Mossalayi MD, Damais C, Kolb JP. Nitric oxide production by human monocytes: Evidence for a role of CD23. Immunol Today 1995; 16: 574-580.
10. Delespesse G, Suter U, Mossalayi D et al. Expression, structure, and function of the CD23 antigen. Adv Immunol 1991; 49: 149-191.
11. Nacher M, Singhasivanon P, Traore B et al. Helminth infections are associated with protection from cerebral malaria and increased nitrogen derivatives concentrations in Thailand. Am J Trop Med Hygiene 2002; 66: 304-309.
12. Fremeaux-Bacchi V, Kolb JP, Rakotobe S, Kazatchkine MD, Fischer EM. Functional properties of soluble CD21. Immunopharmacology 1999; 42: 31-37.
13. Nacher M, Singhasivanon P, Gay F, Silachamroon U, Looareesuwan S. Case-control studies on host factors in severe malaria. Trends Parasitol 2001; 17: 253-254.
14. Ross EM. Pharmacodynamics, 9th Edn. New York: McGraw-Hill; 1995: 29-41.
15. Yan Y, Inuo G, Akao N, Tsukidate S, Fujita K. Down-regulation of murine susceptibility to cerebral malaria by inoculation with third-stage larvae of the filarial nematode Brugia pahangi. Parasitology 1997; 114: 333-338.
16. Larcher C, Kempkes B, Kremmer E et al. Expression of Epstein-Barr virus nuclear antigen-2 (EBNA2) induces CD21/CR2 on B and T cell lines and shedding of soluble CD21. Eur J Immunol 1995; 25: 1713-1719.
17. McNearney TA, Ebenbichler CF, Totsch M, Dierich MP. Expression of complement receptor 2 (CR2) on HTLV-1-infected lymphocytes and transformed cell lines. Eur J Immunol 1993; 23: 1266-1270.
18. Biggar RJ, Gigase PL, Melbye M et al. ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancet 1985; 8454: 520-523.